GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (NAS:APDN) » Definitions » Shiller PE Ratio

APDN (Applied DNA Sciences) Shiller PE Ratio : (As of Apr. 01, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Applied DNA Sciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Applied DNA Sciences Shiller PE Ratio Historical Data

The historical data trend for Applied DNA Sciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences Shiller PE Ratio Chart

Applied DNA Sciences Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Applied DNA Sciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Applied DNA Sciences's Shiller PE Ratio

For the Diagnostics & Research subindustry, Applied DNA Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied DNA Sciences's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Applied DNA Sciences's Shiller PE Ratio falls into.


;
;

Applied DNA Sciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Applied DNA Sciences's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Applied DNA Sciences's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-28/133.1571*133.1571
=-28.000

Current CPI (Dec. 2024) = 133.1571.

Applied DNA Sciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -4,344.659 99.621 -5,807.226
201506 -3,111.512 100.684 -4,115.056
201509 -923.715 100.392 -1,225.195
201512 -4,869.002 99.792 -6,496.909
201603 -5,769.755 100.470 -7,646.868
201606 -5,602.348 101.688 -7,336.084
201609 -4,018.429 101.861 -5,253.064
201612 -6,020.340 101.863 -7,869.917
201703 -5,211.027 102.862 -6,745.775
201706 -3,817.031 103.349 -4,917.941
201709 -4,173.506 104.136 -5,336.618
201712 -4,233.660 104.011 -5,420.017
201803 -2,854.001 105.290 -3,609.386
201806 -3,840.057 106.317 -4,809.502
201809 -4,621.387 106.507 -5,777.763
201812 -3,634.067 105.998 -4,565.202
201903 -2,849.159 107.251 -3,537.380
201906 -1,542.705 108.070 -1,900.833
201909 -1,278.118 108.329 -1,571.046
201912 -1,120.000 108.420 -1,375.538
202003 -790.000 108.902 -965.956
202006 -720.000 108.767 -881.452
202009 -780.000 109.815 -945.796
202012 -880.000 109.897 -1,066.257
202103 -210.000 111.754 -250.218
202106 -480.000 114.631 -557.573
202109 -620.000 115.734 -713.336
202112 -630.000 117.630 -713.163
202203 -230.000 121.301 -252.480
202206 -130.000 125.017 -138.465
202209 10.000 125.227 10.633
202212 -300.000 125.222 -319.011
202303 45.500 127.348 47.576
202306 -240.000 128.729 -248.256
202309 -268.000 129.860 -274.805
202312 -86.500 129.419 -88.998
202403 -265.500 131.776 -268.282
202406 23.500 132.554 23.607
202409 -15.985 133.029 -16.000
202412 -28.000 133.157 -28.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Applied DNA Sciences  (NAS:APDN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Applied DNA Sciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied DNA Sciences Business Description

Traded in Other Exchanges
N/A
Address
50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
Executives
Clay Shorrock officer: Chief Legal Officer C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Scott L Anchin director 16990 GOLDENTOP ROAD, SUITE A, SAN DIEGO CA 92127
William W Montgomery 10 percent owner 34211 SEAVEY LOOP RD., EUGENE OR 97405
Judith Murrah officer: Chief Information Officer C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Beth Jantzen officer: Chief Financial Officer C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Yacov A Shamash director
Robert B Catell director 62 OSBORNE ROAD, GARDEN CITY NY 11530
John Iii Bitzer director C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Joseph D. Ceccoli director C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Elizabeth M. Ferguson director 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Charles S. Ryan director C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
James A Hayward director, officer: Chief Executive Officer C/O 25 HEALTH SCIENCES DRIVE, SUITE 113, NEW YORK NY 11790
Karol Gray officer: Chief Financial Officer C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Ming-hwa Benjamin Liang officer: Strategic Tech. Dev. Officer C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Yacov Shamash director 100 ENGINEERING, STATE UNIVERSITY OF NY, STONE BROOK NY 117942200